Macrophage inflammatory protein-1 alpha production in lipopolysaccharide-stimulated human adherent blood mononuclear cells is inhibited by the nitric oxide synthase inhibitor N(G)-monomethyl-L-arginine
The DOI matches its Crossref record.
Abstract
The release of chemokines such as macrophage-inflammatory protein-1 alpha (MIP-1 alpha) from activated macrophages is a crucial step in cell recruitment necessary for establishing local inflammatory responses. To ascertain the importance of the L-arginine/nitric oxide (NO) pathway in LPS-induced MIP-1 alpha release, we stimulated human adherent PBMC with LPS in the presence of the NO synthase inhibitor N(G)-monomethyl-L-arginine (L-NMMA). L-NMMA decreased LPS-induced MIP-1 alpha protein release (45.5% inhibition) and steady state levels of mRNA (48% inhibition) in adherent PBMC. The concentration of L-NMMA for inhibition of MIP-1 alpha release was dependent on the concentration of L-arginine in the cell culture medium, emphasizing the L-arginine-related action of the drug. Most of the MIP-1 alpha release was attributed to the activity of IL-1 and TNF, since coincubation of LPS-stimulated PBMC with IL-1R antagonist and TNF-binding protein abrogated LPS-induced MIP-1 alpha release (by 76.8%). Analysis of cytokine secretion revealed that, in addition to MIP-1 alpha, L-NMMA inhibited the release of mature IL-1 beta (by 70%) and TNF-alpha (by 53%). In contrast, release of macrophage chemoattractant protein-1 was unaffected; IL-10 was augmented (123.4%) by L-NMMA. In the presence of exogenous NO provided by NO donors, LPS-induced MIP-1 alpha release was enhanced. We concluded that endogenous NO acts as a mediator of inflammation. Since IL-10 is a potent anti-inflammatory cytokine, these data also suggest that L-NMMA acts as an anti-inflammatory agent by specifically altering the balance of pro- and anti-inflammatory cytokines released from LPS-stimulated human PBMC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bean, A. G. D., Roach, D. R., Briscoe, H., France, M. P., Korner, H., Sedgwick, J. D., & Britton, W. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3504 · Cited by 618
Mastroeni, P., Vazquez-Torres, A., Fang, F. C., Xu, Y., Khan, S., Hormaeche, C. E., & Dougan, G. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.237 · Cited by 399
“Nitrogen oxides are known to play a role in the positive regulation of macrophage inhibitory protein (MIP)-1a, a powerful chemoattractant for macrophages (51), and have additional important immunoregulatory properties (52).”
BackgroundVascular endothelial dysfunction in cirrhosis
Iwakiri, Y., & Groszmann, R. J. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.006 · Cited by 312
Kobayashi, Y. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310149 · Cited by 306
Baker, C. A., Martin, D., & Manuelidis, L. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10905-10913.2002 · Cited by 128
High Serum Levels of INOS and MIP-1α Are Associated with Post-Stroke Depression
Wang, X., Fang, C., Liu, X., Wei, W., Zhang, M., Chen, S., & Shi, F. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s320072 · Cited by 14
“Moreover, the expression of MIP-1α was significantly inhibited by NOS inhibitor.(19) Based on the above evidence, iNOS and MIP-1α may jointly lead to the occurrence of depressive symptoms.”
Background
Metadata
- Authors
- Mühl, H., & Dinarello, C. A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-11
- Volume
- 159
- Issue
- 10
- Pages
- 5063-5069
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1534207743
- Cited by
- 52
- References
- 0
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.